(Q83936984)

English

Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization

scientific article published on 03 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

systemic immune response

1 reference

based on heuristic

inferred from title

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

based on heuristic

inferred from title

author name string

Sandrine A L Audouy

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Maarten L van Roosmalen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jolanda Neef

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Rolf Kanninga

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Eduard Post

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mariëlle van Deemter

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Heidi Metselaar

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Saskia van Selm

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

George T Robillard

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Kees J Leenhouts

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Peter W M Hermans

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

3 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

5434-5441

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Novel surface display system for proteins on non-genetically modified gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Complete Genome Sequence of a Virulent Isolate of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.03.054

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.03.054

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16757068%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83936984&oldid=1624991640"